Can tirzepatide cause depression? Trials show no clear link, but some users report mood changes. Here's what to watch for and when to talk to your doctor.
Current evidence does not show that tirzepatide causes depression. In the phase 3 trials that supported its approval, depression and suicidal thoughts were reported at rates similar to placebo, and major regulatory reviews have not confirmed a causal link between GLP-1 medicines and depression. That said, a small number of people do report low mood, anxiety, or emotional flatness while taking tirzepatide, so mood changes are worth tracking and reporting to a healthcare professional.
What the Research Shows About Tirzepatide and Depression
Tirzepatide is the active ingredient in Mounjaro and Zepbound. It is a dual GIP and GLP-1 receptor agonist approved in the United States for type 2 diabetes and chronic weight management.
Depression has not emerged as a common side effect in the trials that supported those approvals. Across the SURPASS and SURMOUNT programs, psychiatric events such as depression and suicidal ideation were reported at rates comparable to placebo.
Regulators reached similar conclusions. The FDA reviewed reports of suicidal thoughts and behaviors in people using GLP-1 receptor agonists and announced in January 2024 that it found no evidence of a causal association. The European Medicines Agency's safety committee reached a comparable conclusion in April 2024 for the GLP-1 class, including tirzepatide.
Tirzepatide has not been shown to cause depression in randomized clinical trials or in regulatory safety reviews.
| Evidence source | What it found |
|---|---|
| Phase 3 trials (SURPASS, SURMOUNT) | Depression and suicidal ideation reported at rates similar to placebo |
| FDA review, January 2024 | No evidence that GLP-1 receptor agonists cause suicidal thoughts or actions |
| EMA safety review, April 2024 | No causal link confirmed for GLP-1 medicines, including tirzepatide |
| Postmarketing reports | Rare reports of low mood, anxiety, and depression; reports alone cannot prove cause |
Tirzepatide vs. Semaglutide and Other GLP-1 Medicines
Mood-related reports have been studied most closely for this drug class as a whole rather than for tirzepatide alone, and the pattern looks similar across products.
| Medication | Drug class | Mood findings in trials | Postmarketing reports |
|---|---|---|---|
| Tirzepatide (Mounjaro, Zepbound) | Dual GIP/GLP-1 agonist | No increased risk vs. placebo | Rare reports of mood changes |
| Semaglutide (Ozempic, Wegovy, Rybelsus) | GLP-1 agonist | No increased risk vs. placebo | Rare reports of depression or suicidal ideation |
| Liraglutide (Victoza, Saxenda) | GLP-1 agonist | No increased risk vs. placebo | Similar rare reports |
| Dulaglutide (Trulicity) | GLP-1 agonist | No increased risk vs. placebo | Similar rare reports |
None of these medicines are approved to treat depression, and none are proven to improve it either. Research into whether GLP-1 drugs have antidepressant effects is still early and mixed.
Newer candidates are also being compared. Some researchers and patients look at cagrilintide vs tirzepatide when weighing future weight-loss options, but psychiatric safety data for cagrilintide is not yet mature.
Why Some People Still Report Mood Changes
Individual reports deserve attention even when the trial data are reassuring. Several indirect factors can affect mood while taking tirzepatide:
- Rapid weight loss. Shedding a large amount of weight quickly changes hormones, energy levels, and body image.
- Reduced appetite. Many people describe the constant "food noise" going quiet. For some this feels freeing; for others it feels like emotional flatness.
- Gastrointestinal side effects. Nausea, vomiting, constipation, and fatigue can wear anyone down.
- Low blood sugar. Hypoglycemia, especially when tirzepatide is combined with insulin or a sulfonylurea, can cause anxiety-like symptoms.
- Sleep disruption. Poor sleep worsens mood and is common when appetite and digestion change.
- Pre-existing conditions. A personal or family history of depression, bipolar disorder, or anxiety raises the chance of a flare during any major change.
- Life stress. Cost, insurance hurdles, supply shortages, and injection routines add their own pressure.
These factors do not mean the medication is risk-free. They mean the cause of a low mood on tirzepatide is not always the drug itself.
Warning Signs That Need Prompt Attention
Contact a healthcare professional promptly if you notice any of the following while taking tirzepatide:
- Sadness, emptiness, or irritability that lasts more than two weeks
- Loss of interest in activities you normally enjoy
- Major changes in sleep, appetite, or energy that are not explained by the medication's usual effects
- Feeling hopeless, worthless, or like a burden to others
- Anxiety or panic that interferes with daily life
- Any thoughts of self-harm or suicide
If you are having thoughts of suicide, call or text 988 in the United States to reach the Suicide and Crisis Lifeline. This is a free, 24-hour service.
Depression and suicidal thoughts are medical emergencies, not side effects to wait out alone.
What to Do If You Feel Depressed on Tirzepatide
- Tell your prescriber. Describe when symptoms started, how severe they are, and whether they changed after a dose increase.
- Do not stop the medication abruptly on your own. Ask your clinician whether a dose reduction, a pause, or a switch makes sense for you.
- Ask about screening. A short questionnaire such as the PHQ-9 can help quantify what you are feeling and guide treatment.
- Treat the depression directly. Therapy, lifestyle changes, and antidepressants can all be appropriate alongside weight-loss treatment.
- Review every other medication and supplement you take, including compounded or gray-market peptides that may not match what the label claims.
Some people continue tirzepatide with extra support. Others do better switching to a different medication. There is no single right answer, and the decision should be made with a clinician who knows your history.
Other Safety Questions People Ask
Mood is only one concern that comes up after starting a GLP-1. Other common questions include:
- Dry mouth. People often ask does tirzepatide cause dry mouth, and the answer is yes for some users; reduced saliva flow is usually mild and tied to dehydration or nausea.
- Hair loss. Rapid weight loss is a frequent trigger for temporary shedding, which is why many people also search can semaglutide cause hair loss after starting a GLP-1.
- Pregnancy. If you are pregnant or planning to conceive, ask can you take tirzepatide while pregnant before continuing; tirzepatide is not recommended during pregnancy, and weight-loss treatment is typically paused.
- Compounded products and stacking. Unverified suppliers and self-mixed peptides add unknown risks; anyone researching aod 9604 and tirzepatide together side effects should talk with a clinician first, because these combinations have not been tested for safety.
Compounded tirzepatide has not been reviewed by the FDA for safety, effectiveness, or psychiatric side effects.
The short version: tirzepatide does not appear to cause depression at the population level, but your own mood matters more than the average. Track how you feel, report changes early, and get professional help without delay if symptoms persist or worsen.
Frequently Asked Questions
Can tirzepatide cause depression?
Clinical trials and FDA and EMA safety reviews have not found that tirzepatide causes depression. Depression and suicidal thoughts appeared at rates similar to placebo in the phase 3 studies. However, a small number of people report low mood, anxiety, or emotional flatness while taking it, so any persistent mood change should be reported to your prescriber.
Does Mounjaro or Zepbound cause suicidal thoughts?
Regulators have not confirmed a causal link between tirzepatide and suicidal thoughts. The FDA announced in January 2024 that it found no evidence that GLP-1 receptor agonists cause suicidal thoughts or actions, and the EMA reached a similar conclusion in April 2024. Rare postmarketing reports exist, so new or worsening thoughts of self-harm should be treated as an emergency and reported immediately.
What should I do if I feel depressed while taking tirzepatide?
Tell your prescriber right away and describe when your symptoms started and how they changed with dosing. Do not stop tirzepatide abruptly on your own, since your clinician may recommend a dose adjustment, a pause, or a different medication. If you have thoughts of suicide, call or text 988 in the United States for free, 24-hour crisis support.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.